Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate.
Rohatgi R
,
Ho HY
,
Kirschner MW
.
???displayArticle.abstract???
Neuronal Wiskott-Aldrich Syndrome protein (N-WASP) transmits signals from Cdc42 to the nucleation of actin filaments by Arp2/3 complex. Although full-length N-WASP is a weak activator of Arp2/3 complex, its activity can be enhanced by upstream regulators such as Cdc42 and PI(4,5)P(2). We dissected this activation reaction and found that the previously described physical interaction between the NH(2)-terminal domain and the COOH-terminal effector domain of N-WASP is a regulatory interaction because it can inhibit the actin nucleation activity of the effector domain by occluding the Arp2/3 binding site. This interaction between the NH(2)- and COOH termini must be intramolecular because in solution N-WASP is a monomer. Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) influences the activity of N-WASP through a conserved basic sequence element located near the Cdc42 binding site rather than through the WASp homology domain 1. Like Cdc42, PI(4,5)P(2) reduces the affinity between the NH(2)- and COOH termini of the molecule. The use of a mutant N-WASP molecule lacking this basic stretch allowed us to delineate a signaling pathway in Xenopus extracts leading from PI(4, 5)P(2) to actin nucleation through Cdc42, N-WASP, and Arp2/3 complex. In this pathway, PI(4,5)P(2) serves two functions: first, as an activator of N-WASP; and second, as an indirect activator of Cdc42.
Figure 1. Sequence determinants of the interaction between the NH2- and COOH-terminal regions of N-WASP. (A) A summary of the nomenclature and amino acid boundaries of the various domains and fragments of bovine N-WASP described in this study. (B) GST-VCA (or GST alone as a control) immobilized on glutathione-Sepharose beads was tested for its ability to pull down various fragments of N-WASP (shown in A) produced as Myc-tagged (MT), 35S-labeled proteins. (C) Dose-dependent binding of the indicated N-WASP fragments to GST-VCA beads. The slope of the line defined by each set of points is inversely proportional to the dissociation constant. (D) GST fusions of the indicated subfragments of the VCA segment of N-WASP (defined in A) were immobilized on glutathione-Sepharose beads and used to pull down the MT-WG fragment from the NH2 terminus of N-WASP. In B and D, 5% of the input and 33% of the pulled down material was analyzed on a 5–15% SDS–polyacrylamide gel.
Figure 2. The NH2-terminal domain of N-WASP inhibits binding of Arp2/3 complex to the COOH-terminal VCA segment in a Cdc42- and PI(4,5)P2-regulated manner. (A) Purified protein preparations of the hexahistidine-tagged (HT) WG and WGP fragments and GST-VCA used in this study are shown on a 5–15% SDS–polyacrylamide gel. (B) Binding of GST-VCA or GST-fused full-length N-WASP (0.5 μM each) to Arp2/3 complex (0.1 μM) was assayed by incubating the components in solution and capturing the GST fusion protein on glutathione-Sepharose beads. The amount of Arp2/3 bound was determined by analyzing 50% of the input and 37.5% of the pulled down material on an α-Arp2 immunoblot. (C) Binding of GST-VCA (0.2 μM) to Arp2/3 (0.1 μM) was tested (as in B) in the presence of the indicated concentrations of HT-WG or HT-WGP. Immunoblotting was used to assay the amount of GST-VCA (α-GST), Arp2/3 (α-Arp3 and α-p34Arc), and HT-WG or HT-WGP (α-pentaHis) precipitated on the glutathione-Sepharose beads. (D) The ability of HT-WG (2 μM) to inhibit the binding of Arp2/3 (0.1 μM) to GST-VCA (0.2 μM) was tested in the presence of GTPγS-loaded Cdc42 (5 μM) or PI(4,5)P2-containing vesicles (100 μM; PI(4,5)P2/PI/PC = 10:45:45). (E) GST-Cdc42 beads, loaded with either GTPγS or GDP, were tested for their abilities to bind to Arp2/3 (1 μM) in the presence of N-WASP (1 μM) and PI(4,5)P2-containing vesicles (100 μM). Arp2/3 pulled down by GST-Cdc42 beads in the absence of any N-WASP represents nonspecific, background binding under the conditions of the assay. For the α-Arp2 immunoblot, 7.5% of the input, 10% of the material pulled down on the GST-Cdc42 beads, and (as a control for comparison) 10% of the material pulled down by GST-VCA (1 μM) on glutathione- Sepharose beads was loaded on the gel.
Figure 3. The NH2-terminal domain of N-WASP does not inhibit binding of G-actin to the VCA segment. GST pull-down assays were used to measure the binding of actin (0.05 μM) to GST-CA, GST-N-WASP, GST-VCA (0.5 μM each), or to GST-VCA (0.5 μM) in the presence of HT-WG or HT-WGP (2.5 μM each). The amount of actin bound was compared using an α-actin immunoblot, loading 100% of the input and 40% of the pulled down material. The amounts of GST-N-WASP, GST-CA, GST-VCA, HT-WG, and HT-WGP pulled down were compared by immunoblotting with α-GST or α-pentaHis.
Figure 4. The NH2-terminal domain of N-WASP inhibits Arp2/3-mediated actin nucleation activity of the VCA segment in a Cdc42, and PI(4,5)P2-regulated manner. (A) The pyrene actin assay was used to monitor the polymerization of 1.3 μM G-actin (1 μM unlabeled actin + 0.3 μM pyrene labeled actin) in the presence of Arp2/3 (30 nM), GST-VCA (10 nM), and the indicated concentrations of HT-WG. (B) The ability of GST-VCA (10 nM or 50 nM) to activate Arp2/3 complex (30 nM) was measured in the presence of increasing concentrations of HT-WG. The maximum polymerization rate, calculated from the linear phase of polymerization curves of the type shown in A, is taken as a measure of Arp2/3 activation. (C) Cdc42-GTPγS can stimulate actin polymerization (1.3 μM actin, 30 nM Arp2/3) in the presence of GST-VCA (5 nM) and HT-WG (200 nM) more effectively than Cdc42-GDP. (D) The ability of either Cdc42-GTPγS (200 nM), PI(4,5)P2-containing vesicles (10 μM), or both together to stimulate actin polymerization (1.3 μM actin, 30 nM Arp2/3 complex) in the presence of GST-VCA (5 nM) and HT-WG (200 nM).
Figure 5. Hydrodynamic characterization of N-WASP. (A) A purified preparation of untagged rat N-WASP used for analytical ultracentrifugation and gel filtration chromatography is shown on a 10% SDS–polyacrylamide gel. (B) A radial absorbance plot showing the equilibrium distribution of N-WASP (0.55 mg/ml, 10 μM) after sedimentation in an analytical ultracentrifuge. The solid line indicates the best fit to the data, assuming a single component model, and the top panel shows residuals of the fit. (C) Elution profile from gel filtration chromatography of N-WASP on an analytical grade Superdex 200 column. The volumes at which various standard proteins elute are indicated.
Figure 6. The WH1 domain is not required for the ability of PI(4,5)P2 to activate N-WASP. (A) A 10% SDS–polyacrylamide gel showing purified protein preparations of GST-tagged wild-type N-WASP (GST-N-WASP) or a GST-tagged truncation mutant of N-WASP lacking the WH1 domain (GST-(ΔWH1) N-WASP). (B) Actin polymerization (1.3 μM actin, 30 nM Arp2/3 complex) in the presence of the indicated combinations of GST-N-WASP (50 nM), GST-(ΔWH1)N-WASP (50 nM), Cdc42-GTPγS (100 nM), or PI(4,5)P2-containing vesicles (1 μM).
Figure 7. The BR in the NH2 terminus of N-WASP specifically binds to PI(4,5)P2. (A) Diagram showing various mutants of the GBR of bovine N-WASP, which includes the BR and the Cdc42/Rac interactive binding (CRIB) motif. In GBR4, the four Xs denote the substitution of four lysine residues (numbers 186, 189, 192, and 195) with glutamic acid residues. (B) Binding of the GST-GBR mutants shown in A to [3H]phosphatidylcholine-labeled vesicles of the indicated compositions. A GST fusion of the β spectrin pleckstrin homology domain (GST-SpecPH) was used as a positive control in the assay.
Figure 8. The BR in the NH2 terminus is required for the ability of PI(4,5)P2 to activate N-WASP. (A) A 10% SDS–polyacrylamide gel showing purified protein preparations of wild-type GST-N-WASP or a GST-tagged mutant of N-WASP containing an internal deletion of the BR (GST-(ΔB)N-WASP). (B) The maximum rate of polymerization was used to quantitate Arp2/3 activity (1.3 μM actin, 30 nM Arp2/3 complex) in the presence of two different concentrations of GST-N-WASP or GST-(ΔB) N-WASP and the indicated combinations of Cdc42-GTPγS (450 nM) and PI(4,5)P2-containing vesicles. While the data shown in B is at 1 μM lipid, GST-(ΔB)N-WASP was PI(4,5)P2-insensitive at higher lipid concentrations as well (up to 5 μM).
Figure 9. N-WASP is required for PI(4,5)P2-stimulated actin polymerization in Xenopus HSS. (A) Affinity-purified α-N-WASP antibody or antibody buffer (mock) was used to immunodeplete N-WASP from Xenopus HSS, and the material in the supernatant was analyzed for the presence of N-WASP by immunoblotting using the same α-N-WASP antibody. (B) Comparison of actin assembly stimulated by 100 μM PI(4,5)P2-containing vesicles in mock-depleted HSS, α-N-WASP–depleted HSS, and in depleted HSS reconstituted with 50 nM recombinant N-WASP. The add back of recombinant N-WASP to α-N-WASP–depleted extracts and the addition of PI(4,5)P2-containing vesicles was performed at the time points indicated by the arrows. (C and D) The abilities of GST-N-WASP, GST-(ΔWH1)N-WASP, or GST-(ΔB)N-WASP (100 nM each) to restore PI(4,5)P2-stimulated actin polymerization to HSS depleted of endogenous N-WASP.
Figure 10. Two models for N-WASP activation. A black circle has been placed between sequence elements or proteins that have been shown to physically interact.
Abdul-Manan,
Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein.
1999, Pubmed
Abdul-Manan,
Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein.
1999,
Pubmed
Aspenström,
Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome.
1996,
Pubmed
Banin,
Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases.
1996,
Pubmed
Bear,
SCAR, a WASP-related protein, isolated as a suppressor of receptor defects in late Dictyostelium development.
1998,
Pubmed
Bi,
Actin polymerization: Where the WASP stings.
1999,
Pubmed
Carlier,
GRB2 links signaling to actin assembly by enhancing interaction of neural Wiskott-Aldrich syndrome protein (N-WASp) with actin-related protein (ARP2/3) complex.
2000,
Pubmed
Cooper,
Pyrene actin: documentation of the validity of a sensitive assay for actin polymerization.
1983,
Pubmed
Derry,
Isolation of a novel gene mutated in Wiskott-Aldrich syndrome.
1994,
Pubmed
Egile,
Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility.
1999,
Pubmed
Hall,
Rho GTPases and the actin cytoskeleton.
1998,
Pubmed
Kim,
Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein.
2000,
Pubmed
Kolluri,
Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42.
1996,
Pubmed
Lei,
Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch.
2000,
Pubmed
Li,
Bee1, a yeast protein with homology to Wiscott-Aldrich syndrome protein, is critical for the assembly of cortical actin cytoskeleton.
1997,
Pubmed
Ma,
Corequirement of specific phosphoinositides and small GTP-binding protein Cdc42 in inducing actin assembly in Xenopus egg extracts.
1998,
Pubmed
,
Xenbase
Ma,
The Arp2/3 complex mediates actin polymerization induced by the small GTP-binding protein Cdc42.
1998,
Pubmed
,
Xenbase
Machesky,
Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex.
1999,
Pubmed
Machesky,
Signaling to actin dynamics.
1999,
Pubmed
Miki,
N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases.
1996,
Pubmed
Miki,
Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP.
1998,
Pubmed
Miki,
Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.
1998,
Pubmed
Miki,
WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac.
1998,
Pubmed
Mullins,
The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments.
1998,
Pubmed
Mullins,
How WASP-family proteins and the Arp2/3 complex convert intracellular signals into cytoskeletal structures.
2000,
Pubmed
Rameh,
A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains.
1997,
Pubmed
Ramesh,
WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells.
1997,
Pubmed
Rivero-Lezcano,
Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains.
1995,
Pubmed
Rohatgi,
The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly.
1999,
Pubmed
,
Xenbase
Rozelle,
Phosphatidylinositol 4,5-bisphosphate induces actin-based movement of raft-enriched vesicles through WASP-Arp2/3.
2000,
Pubmed
She,
Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells.
1997,
Pubmed
Suetsugu,
Identification of two human WAVE/SCAR homologues as general actin regulatory molecules which associate with the Arp2/3 complex.
1999,
Pubmed
Suzuki,
Neural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneri.
1998,
Pubmed
,
Xenbase
Svitkina,
Arp2/3 complex and actin depolymerizing factor/cofilin in dendritic organization and treadmilling of actin filament array in lamellipodia.
1999,
Pubmed
,
Xenbase
Symons,
Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization.
1996,
Pubmed
Winter,
Activation of the yeast Arp2/3 complex by Bee1p, a WASP-family protein.
1999,
Pubmed
Yarar,
The Wiskott-Aldrich syndrome protein directs actin-based motility by stimulating actin nucleation with the Arp2/3 complex.
1999,
Pubmed
Zigmond,
How WASP regulates actin polymerization.
2000,
Pubmed
